Human interleukin-6 receptor expression inhibitor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 22, 2003
Grant Date -
N/A
app pub date -
Jun 16, 1997
filing date -
Dec 16, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention discloses an expression inhibitor of human interleukin-6 receptor (human IL-6R) comprising as its active ingredient an antisense oligonucleotide derivative that hybridizes to a region of at least 9 to 30 consecutive nucleotide sequences that contains a nucleotide sequence of a portion being able to form a loop structure of mRNA that codes for human IL-6R.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully